JangoCell

JangoCell is a biotechnology company and contract research organization (CRO) focused on the development of cell-based therapies and providing specialized cell biology products and services. The company is pioneering a novel approach to hormone replacement therapy using cell-based treatments to restore natural hormone balance and treat age-related diseases such as Alzheimer's and diabetes. In addition to its internal R&D, JangoCell offers a wide range of services including custom cell line development, cell characterization, and biobanking. Their product catalog features various cell types, media, and reagents designed to support academic and pharmaceutical research. By combining therapeutic development with CRO services, JangoCell aims to accelerate the translation of regenerative medicine from the lab to the clinic.